Alarm raised over STI drug resistance

Governments throughout the world have been urged to adopt new guidelines on the treatment of sexually transmitted infections in a bid to tackle antibiotic resistance.

The World Health Organisation warns that some strains of gonorrhoea now do not respond to any available antibiotic.

And its guidance says that quinolone antibiotics should not be used for the treatment of gonorrhoea because of widespread and high levels of resistance.

WHO says syphilis should be treated with a single, injected dose of benzathine penicillin.

It promises to monitor global availability of the drug, which is in short supply in many countries.

According to WHO estimates, some 78 million people globally contract gonorrhoea and 5.6 million develop syphilis. Some 131 million people are infected with chlamydia.

Ian Askew, from WHO, said: “Chlamydia, gonorrhoea and syphilis are major public health problems worldwide, affecting millions of peoples’ quality of life, causing serious illness and sometimes death. The new WHO guidelines reinforce the need to treat these STIs with the right antibiotic, at the right dose, and the right time to reduce their spread and improve sexual and reproductive health.

"To do that, national health services need to monitor the patterns of antibiotic resistance in these infections within their countries."

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index